source
- 10 clinical trials to watch in the second half of 2026The biotechnology sector’s upswing accelerated in the first half. Positive results from anticipated trials in lung cancer, Alzheimer’s and multiple autoimmune conditions could add to the momentum.BioPharma Dive · 1mo ago↗ source
- La Ceiba Foods Latin Market Inc. Recalls Cottage Cheese Products Because of Possible Health RiskJune 26, 2026, – La Ceiba Foods Latin Market Inc. is conducting a recall of Requesón Salvadoreño (Salvadoran Cottage Cheese) and Requesón Mexicano (Mexican Cottage Cheese) products marketed under t…fda recalls · 1mo ago↗ source
- FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesReplimune’s application is the latest example of changing attitudes at the FDA. Elsewhere, Revolution Medicines outlined more RAS-blocking data and a Definium stock offering brought in $800 million.